Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Ischemic Heart Disease

Free Subscription 29.07.2019 2 Am J Cardiol 1 Am J Med 1 Ann Intern Med 1 Ann Thorac Surg 3 Arterioscler Thromb Vasc Biol 2 Can J Cardiol 1 Catheter Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 2 Circulation 1 Clin Cardiol 1 Eur Heart J 1 Heart 1 Hypertension 18 Int J Cardiol 1 J Am Coll Cardiol 1 J Mol Cell Cardiol 1 J Thorac Cardiovasc Surg 1 Thromb Haemost

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Cardiol

1. KIM CY, Lee JH, Jang SY, Bae MH, et al
   Usefulness of Calculation of Cardiovascular Risk Factors to Predict Outcomes in Patients With Acute Myocardial Infarction.
   Am J Cardiol. 2019 Jun 25. pii: S0002-9149(19)30710.
   PubMed     Text format     Abstract available
   
   
2. MURPHY AC, Yudi MB, Farouque O, Dinh D, et al
   Impact of Gender and Door-to-Balloon Times on Long-Term Mortality in Patients Presenting With ST-Elevation Myocardial Infarction.
   Am J Cardiol. 2019 Jun 24. pii: S0002-9149(19)30708.
   PubMed     Text format     Abstract available
   
   

   
   Am J Med

3. RANA JS, Liu JY, Moffet HH, Sanchez RJ, et al
   Risk of Cardiovascular Events in Statin-Treated Patients with Type 2 Diabetes and Metabolic Dyslipidemia without Prevalent Atherosclerotic Cardiovascular Disease.
   Am J Med. 2019 Jul 22. pii: S0002-9343(19)30577.
   PubMed     Text format     Abstract available
   
   

   
   Ann Intern Med

4. O'BRIEN CW, Juraschek SP, Wee CC
   Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey.
   Ann Intern Med. 2019 Jul 23. pii: 2738925. doi: 10.7326/M19-0953.
   PubMed     Text format    
   
   

   
   Ann Thorac Surg

5. PARKER DM, Owens SL, Ramkumar N, Likosky D, et al
   Galectin-3 as a Predictor of Long-term Survival after Isolated Coronary Artery Bypass Grafting Surgery.
   Ann Thorac Surg. 2019 Jul 20. pii: S0003-4975(19)31038.
   PubMed     Text format     Abstract available
   
   

   
   Arterioscler Thromb Vasc Biol

6. WOLNERHANSSEN BK, Meyer-Gerspach AC
   Letter Regarding Article, "Metabolomic Pattern Predicts Incident Coronary Heart Disease".
   Arterioscler Thromb Vasc Biol. 2019;39:e186.
   PubMed     Text format    
   
   
7. WANG Z, Yu B
   Response Letter Regarding Article, "Metabolomic Pattern Predicts Incident Coronary Heart Disease".
   Arterioscler Thromb Vasc Biol. 2019;39:e187.
   PubMed     Text format    
   
   
8. PALASUBRAMANIAM J, Wang X, Peter K
   Myocardial Infarction-From Atherosclerosis to Thrombosis.
   Arterioscler Thromb Vasc Biol. 2019;39:e176-e185.
   PubMed     Text format    
   
   

   
   Can J Cardiol

9. BRUNHAM LR, Ruel I, Aljenedil S, Riviere JB, et al
   Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018.
   Can J Cardiol. 2018;34:1553-1563.
   PubMed     Text format     Abstract available
   
   
10. BERTIC M, Chue CD, Virani S, Davis MK, et al
    Coronary Vasospasm Following Heart Transplantation: Rapid Progression to Aggressive Cardiac Allograft Vasculopathy.
    Can J Cardiol. 2018;34:1687.
    PubMed     Text format     Abstract available
    
    

    
    Catheter Cardiovasc Interv

11. KOLTOWSKI L, Tomaniak M, Ochijewicz D, Maksym J, et al
    Second generation, sirolimus-eluting, bioresorbable Tyrocore scaffold implantation in patients with ST-segment elevation myocardial infarction: Baseline OCT and 30-day clinical outcomes - A FANTOM STEMI pilot study.
    Catheter Cardiovasc Interv. 2019 Jul 25. doi: 10.1002/ccd.28414.
    PubMed     Text format     Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

12. MYERS KD, Farboodi N, Mwamburi M, Howard W, et al
    Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes.
    Circ Cardiovasc Qual Outcomes. 2019;12:e005404.
    PubMed     Text format     Abstract available
    
    

    
    Circulation

13. BICK AG, Akwo E, Robinson-Cohen C, Lee K, et al
    Association of APOL1 Risk Alleles with Cardiovascular Disease in African Americans in the Million Veteran Program.
    Circulation. 2019 Jul 24. doi: 10.1161/CIRCULATIONAHA.118.036589.
    PubMed     Text format     Abstract available
    
    
14. 
    Correction to: Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
    Circulation. 2019;140:e171.
    PubMed     Text format    
    
    

    
    Clin Cardiol

15. WANG L, Ge H, Peng L, Wang B, et al
    A meta-analysis of the relationship between VEGFR2 polymorphisms and atherosclerotic cardiovascular diseases.
    Clin Cardiol. 2019 Jul 24. doi: 10.1002/clc.23233.
    PubMed     Text format     Abstract available
    
    

    
    Eur Heart J

16. FRANGOGIANNIS NG
    S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges.
    Eur Heart J. 2019 Jul 23. pii: 5537337. doi: 10.1093.
    PubMed     Text format    
    
    

    
    Heart

17. LEE CMY, Mnatzaganian G, Woodward M, Chow CK, et al
    Sex disparities in the management of coronary heart disease in general practices in Australia.
    Heart. 2019 Jul 23. pii: heartjnl-2019-315134. doi: 10.1136/heartjnl-2019-315134
    PubMed     Text format     Abstract available
    
    

    
    Hypertension

18. ZHU L, Jia L, Liu Z, Zhang Y, et al
    Elevated Methylation of FOXP3 (Forkhead Box P3)-TSDR (Regulatory T-Cell-Specific Demethylated Region) Is Associated With Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndrome.
    Hypertension. 2019 Jul 22:HYPERTENSIONAHA11912852.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cardiol

19. TRAN HV, Erskine NA, Nguyen HL, McManus DD, et al
    Increase in white blood cell count is associated with the development of atrial fibrillation after an acute coronary syndrome.
    Int J Cardiol. 2018 Jun 5. pii: S0167-5273(17)37883.
    PubMed     Text format     Abstract available
    
    
20. DANNENBERG L, Wolff G, Naguib D, Pohl M, et al
    Safety and efficacy of Tirofiban in STEMI-patients.
    Int J Cardiol. 2019;274:35-39.
    PubMed     Text format     Abstract available
    
    
21. DERIMAY F, Rioufol G, Cellier G, Souteyrand G, et al
    Benefits of final proximal optimization technique (POT) in provisional stenting.
    Int J Cardiol. 2019;274:71-73.
    PubMed     Text format     Abstract available
    
    
22. CHOE JC, Cha KS, Ahn J, Park JS, et al
    Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different P2Y12 inhibitors in a large observational study.
    Int J Cardiol. 2019;274:21-26.
    PubMed     Text format     Abstract available
    
    
23. RUGGIO A, Pedicino D, Flego D, Vergallo R, et al
    Correlation between CD4(+)CD28(null) T lymphocytes, regulatory T cells and plaque rupture: An Optical Coherence Tomography study in Acute Coronary Syndromes.
    Int J Cardiol. 2019;276:289-292.
    PubMed     Text format     Abstract available
    
    
24. TOPEL ML, Sandesara PB, Stahl EP, Hayek SS, et al
    Mechanisms underlying the J-curve for diastolic blood pressure: Subclinical myocardial injury and immune activation.
    Int J Cardiol. 2019;276:255-260.
    PubMed     Text format     Abstract available
    
    
25. BARRAUD J, Gaubert M, Resseguier N, Camoin-Jau L, et al
    The hidden side of oral thrombin inhibitors.
    Int J Cardiol. 2019;274:186-187.
    PubMed     Text format    
    
    
26. BRIONGOS-FIGUERO S, Estevez A, Luisa Perez M, Martinez-Ferrer JB, et al
    Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
    Int J Cardiol. 2018 Sep 5. pii: S0167-5273(18)34159.
    PubMed     Text format     Abstract available
    
    
27. RUSSO G, Burzotta F, D'Amario D, Ribichini F, et al
    Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction.
    Int J Cardiol. 2019;274:221-225.
    PubMed     Text format     Abstract available
    
    
28. ZHANG P, Ke J, Li Y, Huang L, et al
    Long-term exposure to high altitude hypoxia during pregnancy increases fetal heart susceptibility to ischemia/reperfusion injury and cardiac dysfunction.
    Int J Cardiol. 2019;274:7-15.
    PubMed     Text format     Abstract available
    
    
29. VEROUHIS D, Saleh N, Settergren M, Sorensson P, et al
    Remote ischemic conditioning protects against endothelial ischemia-reperfusion injury via a glucagon-like peptide-1 receptor-mediated mechanism in humans.
    Int J Cardiol. 2019;274:40-44.
    PubMed     Text format     Abstract available
    
    
30. LI WZ, Yang Y, Liu K, Long R, et al
    FGL2 prothrombinase contributes to the early stage of coronary microvascular obstruction through a fibrin-dependent pathway.
    Int J Cardiol. 2019;274:27-34.
    PubMed     Text format     Abstract available
    
    
31. MEYERS HP, Smith SW
    Prospective, real-world evidence showing the gap between ST elevation myocardial infarction (STEMI) and occlusion MI (OMI).
    Int J Cardiol. 2019 Jul 15. pii: S0167-5273(19)32068.
    PubMed     Text format    
    
    
32. SIDDIQUI AJ, Holzmann MJ
    Association between reduced left ventricular ejection fraction following non-ST-segment elevation myocardial infarction and long-term mortality in patients of advanced age.
    Int J Cardiol. 2019 Jul 11. pii: S0167-5273(19)32530.
    PubMed     Text format     Abstract available
    
    
33. MAZIDI M, Mikhailidis DP, Banach M
    Associations between risk of overall mortality, cause-specific mortality and level of inflammatory factors with extremely low and high high-density lipoprotein cholesterol levels among American adults.
    Int J Cardiol. 2019;276:242-247.
    PubMed     Text format     Abstract available
    
    
34. HERTZBERG D, Sartipy U, Lund LH, Ryden L, et al
    Heart failure and the risk of acute kidney injury in relation to ejection fraction in patients undergoing coronary artery bypass grafting.
    Int J Cardiol. 2018 Sep 28. pii: S0167-5273(18)34815.
    PubMed     Text format     Abstract available
    
    
35. BATTY J, Qiu W, Gu S, Sinclair H, et al
    One-year clinical outcomes in older patients with non-ST elevation acute coronary syndrome undergoing coronary angiography: An analysis of the ICON1 study.
    Int J Cardiol. 2019;274:45-51.
    PubMed     Text format     Abstract available
    
    
36. FAXEN J, Xu H, Evans M, Jernberg T, et al
    Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome.
    Int J Cardiol. 2019;274:52-58.
    PubMed     Text format     Abstract available
    
    

    
    J Am Coll Cardiol

37. JABBOUR RJ, Tanaka A, Finkelstein A, Mack M, et al
    Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2018;71:1513-1524.
    PubMed     Text format     Abstract available
    
    

    
    J Mol Cell Cardiol

38. CHEN J, Luo Y, Wang S, Zhu H, et al
    Roles and mechanisms of SUMOylation on key proteins in myocardial ischemia/reperfusion injury.
    J Mol Cell Cardiol. 2019 Jul 22. pii: S0022-2828(19)30151.
    PubMed     Text format     Abstract available
    
    

    
    J Thorac Cardiovasc Surg

39. RYAN CT, Ghanta RK
    Commentary: "Shear" patience for post-myocardial infarction regenerative therapy.
    J Thorac Cardiovasc Surg. 2019 Jul 2. pii: S0022-5223(19)31324.
    PubMed     Text format    
    
    

    
    Thromb Haemost

40. KAIKITA K, Hosokawa K, Dahlen JR, Tsujita K, et al
    Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease.
    Thromb Haemost. 2019 Jul 22. doi: 10.1055/s-0039-1693411.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: